This inventor holds 1 USPTO granted patent. Top assignee: Fujimoto Co., Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Sachiko Hiraide: Innovator in ADHD Treatment
Introduction
Sachiko Hiraide is a notable inventor based in Hokkaido, Japan. She has made significant contributions to the field of pharmacology, particularly in the treatment of attention-deficit/hyperactivity disorder (ADHD). Her innovative work has led to the development of a unique therapeutic agent that addresses this condition.
Latest Patents
Hiraide holds a patent for a prophylactic and therapeutic agent for ADHD. The patent describes the use of 1-(benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof. This compound has been recognized for its effectiveness as an antidepressant, psychotropic drug, antiparkinsonian drug, and anti-Alzheimer's disease drug. However, Hiraide's research has revealed its potential in preventing and treating ADHD, marking a significant advancement in therapeutic options for this disorder.
Career Highlights
Throughout her career, Hiraide has focused on innovative solutions in pharmacology. Her dedication to research and development has led to the successful patenting of her work, showcasing her commitment to improving mental health treatments. She is affiliated with Fujimoto Co., Ltd., where she continues to contribute to the field.
Collaborations
Hiraide has worked alongside talented colleagues, including Hiroko Togashi and Fumio Yoneda. Their collaborative efforts have furthered research and development in the area of ADHD treatment.
Conclusion
Sachiko Hiraide's contributions to the field of pharmacology, particularly in ADHD treatment, highlight her innovative spirit and dedication to improving mental health. Her patented work represents a significant step forward in therapeutic options for individuals affected by this condition.